PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer | JCO Precision Oncology
The Landscape of PIK3CA Mutations in Colorectal Cancer - ScienceDirect
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival | NEJM
Frontiers | PIK3CA in Colorectal Cancer
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
Targeting PI3K Signaling as a Therapeutic Approach for Colorectal Cancer - ScienceDirect
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer
Summary for our hypothesis in MEK inhibitor-resistant PIK3CA mt colon... | Download Scientific Diagram
PIK3CA in Colorectal Cancer. - Abstract - Europe PMC
High Frequency of Mutations of the PIK3CA Gene in Human Cancers | Science
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer | Nature Communications
PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-α inhibition | PNAS
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival | PLOS ONE
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders: Trends in Molecular Medicine
PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers | PLOS ONE
Angiogenesis in Cancer
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders: Trends in Molecular Medicine
Mortality among Patients with Colorectal Cancer, According to Regular... | Download Scientific Diagram
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway | Molecular Medicine | Full Text
Frontiers | PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Figure 2 from PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. | Semantic Scholar
Colorectal Cancer and the Targets involved in Mechanism of It- CUSABIO
